Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABRAXANE vs ABROCITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABRAXANE vs ABROCITINIB: Safety Overview

Metric ABRAXANE ABROCITINIB
Total FAERS Reports 303 3,170
Deaths Reported 152 57
Death Rate 50.2% 1.8%
Hospitalizations 124 329
Average Patient Age 60.8 yrs 48.5 yrs
% Female Patients N/A 53.9%
FDA Approval Date N/A Jan 14, 2022
Manufacturer N/A U.S. Pharmaceuticals
Route N/A ORAL
Marketing Status N/A Prescription